Actually, just about any of my posts here related to
health illustrates that principle. But this example is particularly good. Johnson & Johnson are paying their lawyers to fight to keep clinical trial data on
Risperdal hidden from the public.
According to Law360 (where I can’t read the full stories), “Plaintiffs in a cluster of product liability lawsuits…told a Pennsylvania judge on Tuesday that documents detailing the medication’s risks were too vital to the public interest to remain under seal as part of court proceedings.”
Johnson & Johnson
disagrees.
No comments:
Post a Comment